2-Methyl-DiPT

(Redirected from 2-methyl-DiPT)

2-Methyl-DiPT, or 2-Me-DiPT, also known as 2-methyl-N,N-diisopropyltryptamine, is a chemical compound of the tryptamine family related to the psychedelic drug diisopropyltryptamine (DiPT).[1] It is the 2-methyl derivative of DiPT.[1]

2-Methyl-DiPT
Clinical data
Other names2-Me-DiPT; 2-Methyl-N,N-diisopropyltryptamine
Routes of
administration
Unknown[1]
Drug classUnknown[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • N-[2-(2-methyl-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine
Chemical and physical data
FormulaC17H26N2
Molar mass258.409 g·mol−1
3D model (JSmol)
  • CC(N(C(C)C)CCC(C1=CC=CC=C1N2)=C2C)C
  • InChI=1S/C17H26N2/c1-12(2)19(13(3)4)11-10-15-14(5)18-17-9-7-6-8-16(15)17/h6-9,12-13,18H,10-11H2,1-5H3
  • Key:VRRKLUAGPLTKAR-UHFFFAOYSA-N

The drug was mentioned by Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved) as a potentially interesting analogue of DiPT that might likewise produce selective auditory hallucinogenic effects.[1] This was based on findings that other 2-methylated tryptamines like 2-methyl-DMT and 2-methyl-DET have also uniquely been found to produce DiPT-like auditory effects.[1] However, 2-methyl-DiPT is not known to have been synthesized nor tested.[1]

A notable derivative of 2-methyl-DiPT is 5-MeO-2-Me-DiPT.[2][3] In addition, a notable analogue of 2-methyl-DiPT is 2-methyl-iPALT.[4]

2-Methyl-DiPT was first described by Shulgin in TiHKAL in 1997.[1]

See also

edit

References

edit
  1. 1 2 3 4 5 6 7 8 9 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252. "There is an interesting idea tucked away here in what seems to be an uninteresting compound. The sound distortion, mentioned in both of these reports, brings to mind DIPT where it is the major indicator of intoxication. With some people, it is the only change observed. With DIPT, there are two isopropyl groups on the basic nitrogen atom; here there are two ethyl groups. One might speculate that there might well be some optimum group geometry that would make the auditory to visual distortion ratio as high as possible. There were no suggestions that there were any auditory changes with DET so perhaps the added mass of that methyl group at the 2-position brings the molecular weight into some "auditory window." A compelling compound would be, of course, N,N-diisopropyl-2-methyltryptamine (2-Me-DIPT), but I don't believe that it has ever even been synthesized as of the present moment. It would certainly be a simple compound to make."
  2. Brandt SD, Tearavarich R, Dempster N, Cozzi NV, Daley PF (January 2012). "Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines". Drug Test Anal. 4 (1): 24–32. doi:10.1002/dta.398. PMID 22287290.
  3. Caspar AT, Gaab JB, Michely JA, Brandt SD, Meyer MR, Maurer HH (January 2018). "Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS" (PDF). Drug Test Anal. 10 (1): 184–195. doi:10.1002/dta.2197. PMID 28342193.
  4. US 20240277665A1, Daley PF, Cozzi NV, Callaway WB, "Asymmetric allyl tryptamines", issued 4 March 2024, assigned to Alexander Shulgin Research Institute Inc.